newsfilter
← Latest News
Business Wire·

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition," "ACI," or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced that the